This inventor holds 3 USPTO granted patents. Top assignees: University of Arkansas, University of Medicine and Dentistry of New Jersey. Active years: 2002-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 849 
1 out of 272 
Years Active: 2002-2010
Title: Teresita Bellido: Innovator in Osteoblast Research
Introduction
Teresita Bellido is a notable inventor based in Little Rock, AR (US). She has made significant contributions to the field of osteoblast research, particularly in understanding the effects of glucocorticoids on bone health. With a total of 3 patents, her work focuses on innovative therapeutic compositions aimed at preventing abnormal apoptosis responses in cells.
Latest Patents
One of her latest patents provides novel compositions containing a calbindin-D therapeutic element, which is involved in the regulation of apoptosis. These compositions may be administered to prevent an abnormal apoptosis response in various cell types, including osteoblasts and osteocytes. Specifically, her inventions are useful for preventing diseases associated with glucocorticoid-induced cell death, such as glucocorticoid-induced osteoporosis. Another significant patent demonstrates that glucocorticoid-induced bone disease results from changes in the birth and death rates of bone cells. This invention utilizes a murine model of glucocorticoid excess and bone biopsy specimens from patients to show that glucocorticoid administration increases apoptosis of mature osteoblasts and osteocytes, leading to decreased bone formation rates and mineral density.
Career Highlights
Throughout her career, Teresita Bellido has worked with esteemed institutions, including the University of Arkansas and the University of Medicine and Dentistry of New Jersey. Her research has significantly advanced the understanding of bone cell dynamics and the impact of glucocorticoids on bone health.
Collaborations
Teresita has collaborated with notable colleagues such as Stavros C Manolagas and Sylvia Christakos, contributing to a rich exchange of ideas and research findings in the field of bone biology.
Conclusion
Teresita Bellido's innovative work in osteoblast research and her contributions to understanding glucocorticoid effects on bone health have established her as a prominent inventor in her field. Her patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile